B

Bioventix

Organization

Heard in 3 episodes across 3 shows since Mar 2026

A UK biotechnology company that develops and commercializes high-affinity antibodies used in diagnostic tests, particularly in clinical laboratories.

Episodes

3
across 3 shows

First heard

Mar 2026

Expert statements

3
1 positive · 2 negative

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20261
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20260
Sep 20262
Oct 20260

What experts have said about Bioventix

3 statements · 1 positive · 2 negative

  1. Paul ScottNegativeMar 13, 2026· UK Small/Mid Caps with Paul Scott

    Bioventix’s share price has fallen sharply and persistently.

    “I think most— Bioventix is another one that used to be such a quality growth stock, but the share price is just a 45-degree line downwards.”

    Listen at 32:53

    Open the episode · Paul's Podcast - Fri 13 Mar 2026
  2. Paul ScottNegativeMar 13, 2026· UK Small/Mid Caps with Paul Scott

    Bioventix’s 10.5% yield signals doubts about dividend sustainability.

    “10.5% dividend yield, which is saying to you the market doesn't think the dividends are sustainable.”

    Listen at 33:09

    Open the episode · Paul's Podcast - Fri 13 Mar 2026
  3. Paul ScottPositiveMar 13, 2026· UK Small/Mid Caps with Paul Scott

    Bioventix may be entering speculative buying territory.

    “it's got to be coming into having a punt range, hasn't it really, Bioventix?”

    Listen at 33:27

    Open the episode · Paul's Podcast - Fri 13 Mar 2026
Filter the statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

3 episodes featuring Bioventix, newest first

Bioventix · PodLume